ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 398

Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis

Kristofer Andreasson1, Li Alemo Munters1,2 and Helene Alexanderson3,4, 1Karolinska University Hospital, Function Area Occupational therapy and Physical therapy, Stockholm, Sweden, 2Swedish Rheumatism Association, Stockholm, Sweden, 3Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden, 4Function Area Occupational therapy & Physiotherapy, Allied Health Professionals Function, Karolinska University Hospital, Stockholm, Sweden

Meeting: ACR/ARHP Annual Meeting 2018

Keywords: Muscle strength, polymyositis/dermatomyositis (PM/DM) and quality of life

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Muscle Biology, Myositis and Myopathies Poster – ARHP

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Poly- and dermatomyositis (PM/DM) are idiopathic inflammatory muscle diseases characterized by reduced muscle function. Oral glucocorticoids and DMARD’s are the usual treatment options and physical exercise plays an important role in the treatment as well. Despite an often beneficial effect of treatment, most patients are left with sustained muscle impairment and reduced quality of life. It is not known how muscle impairment differ between patients with newly onset PM/DM and patients with established PM/DM. The aim of this study is to investigate muscle function as to maximal isometric strength (MVIC) and isometric muscular endurance (ME) in patients with newly onset, active and established PM/DM. A further aim is to investigate possible correlations between muscle function and health related quality of life (HRQoL).

Methods: All patients diagnosed with PM or DM (n=5, all female) during 170901 and 180401 at Karolinska University hospital in Solna who met the inclusion criteria were asked to participate. Patients with established PM/DM (n=6, all female) where identified through patient register at the same clinic, selected to match recent onset disease group as to age and gender. A dynamometer from Biodex was used to assess MVIC and ME starting with three warm-up 4-sec contractions followed by three similar maximal contractions, all with a 3-minute rest in-between. Thereafter six sets of twelve submaximal repetitions, starting on 20 % of MVIC and increasing by 10 %/set, finishing on 70 % of MVIC. Each set ended with a new maximal contraction registered as percentage of initial MVIC. The participants reported HRQoL using SF–36. Statistical significance was set to p<0.05, Mann-Whitney U-test was used to compare groups and Spearman’s rho for correlations.

Results: Median age for patients with recent onset PM/DM was 36 (min–max 19–64) years and for established disease 61 (42–66) years. Diagnosis duration was 4 (1–6) months and 126 (85–433) for the two groups, respectively. Patients with recent onset disease had a median MVIC of 73 (53–127) Nm and patients with established disease had 58 (41–82) Nm (p=0.22). ME were 83 (63–94) % and 91 (85–98) % for patients with recent onset disease and established PM/DM, respectively (p=0.08). The correlations between ME and General Health was (rs=0.54, CI=-0.08–0.87) with correlations to Physical Function, Physical Role Function, and Social Function varying between (rs=0.40, CI=-0.26–0.81) and (rs=0.48, CI=-0.17–0.84). Correlations between MVIC and Vitality, Physical Role function, Emotional Function and Social Function varied between (rs=-0.49, CI=-0.84–0.16) and (rs=-0.34, CI=-0.78–0.33). Correlations to remaining domains were lower.

Conclusion: No significant differences were found between the groups regarding MVIC and ME. However, there was a trend towards reduced ME in patients with recent onset PM/DM compared to established disease. Correlations between muscle function and HRQoL were moderate at best. Further research is needed with more patients to reach statistical power and improved matching of patients and controls.


Disclosure: K. Andreasson, None; L. Alemo Munters, None; H. Alexanderson, None.

To cite this abstract in AMA style:

Andreasson K, Alemo Munters L, Alexanderson H. Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/muscle-function-and-health-related-quality-of-life-in-patients-with-polymyositis-and-dermatomyositis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2018

ACR Meeting Abstracts - https://acrabstracts.org/abstract/muscle-function-and-health-related-quality-of-life-in-patients-with-polymyositis-and-dermatomyositis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology